CKRA HELPS DEVELOP THE MEDICINES OF TOMORROW!
CURRENT STUDIES
- Adolescent HPV/Meningitis Vaccine
- Adolescent Smoking Cessation
- Asthma
- Diabetic Peripheral Neuropathy
- Fibromyalgia and Depression
- Gout
- Low Testosterone
- Melanoma Vaccine
- Nocturia (frequent nighttime urination)
- Overactive Bladder
- Pediatric Cold Sores
- Smoking Cessation
- Type 1 Diabetes
- Type 2 Diabetes (study #1 - Mt. Sterling office)
- Type 2 Diabetes (study #2 - Mt. Sterling office)
-
VIEW ALL STUDIES: Lexington Mt. Sterling
SIGN UP – STUDY WAITING LIST
TESTIMONIALS
“I have had the pleasure of participating in several studies with CKRA for over ten years, and I haven't been disappointed yet. I love the opportunity to help them do research that benefits not only me, but everyone eventually; getting paid is an added bonus.
The staff is remarkable, friendly and always professional. I highly recommend you participate.”
P.K., Lexington
Study ParticipantCKRA ON FACEBOOK
AIDS gel with Gilead drug protects women in study
Posted in: Latest Articles
Share this:
Share this:
Another reason why clinical research is so important. We can’t find the medicines of tomorrow if we don’t test today.
“VIENNA (Reuters) – A gel containing a prescription drug can sharply reduce HIV infections in women, a study described as groundbreaking by the World Health Organization showed on Monday.
The gel, containing Gilead Sciences AIDS drug tenofovir, reduced HIV infections in women by 39 percent over two and a half years — the first time such an approach has protected against sexual transmission of the virus.”
Information provided by Insight Broadband. Click to read full article.